Risultati per 'Covance':

Di seguito l'elenco dei risultati di ricerca trovati rilevanti per la keyword 'Covance':

Risultati maggiormente rilevanti:

 covance | labcorp
BURLINGTON, N.C. -- (BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as ...

 labcorp portal login - investigator portal
Labcorp Portal Login - Investigator Portal

 labcorp drug development - wikipedia
Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.. Labcorp Drug Development offers services in the preclinical ...

Altri risultati:

 lab r&d testing for biopharma companies | labcorp
We are a laboratory powerhouse. With labs for nonclincial studies and clinical trial testing strategically located around the globe, we have the ability to scale quickly and efficiently, performing more than 15,000 research studies and processing more than 4.4 million clinical trial testing kits annually.

 covance clinical trials
Are you interested in participating in clinical trials that can advance medical science and improve patient care? Covance Clinical Trials is a website that connects you with opportunities to join studies conducted by Covance, a leading global life sciences company and a subsidiary of Labcorp. You can search for trials by location, condition, or eligibility criteria, and learn more about the ...

 labcorp and covance launch extensive preclinical, clinical and post ...
With more than 20 years of experience in delivering development solutions for advanced therapies, such as cell and gene therapy products, Covance provides a unique offering of specialized expertise and coordinated capabilities, combined with focused investments supporting the preclinical, clinical and post-approval phases of development.

 labcorp to acquire covance for approximately $5.6 billion, creating ...
Covance shareholders will own approximately 15.5% of the combined company. The agreed price represents a 32% premium to Covance’s closing stock price of $79.90 on October 31, 2014 and a multiple of approximately 13.3 times Covance’s EBITDA over the last 12 months through September 30, 2014.

Last Search Plugin 2.03

Ricerche correlate

Ricerche simili a 'Covance' effettuate:

Last Search Plugin 2.03